CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Neovasc Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Neovasc Inc
13700 Mayfield Place #2135
Phone: (604) 270-4344p:604 270-4344 RICHMOND, BC  V6V 2E4  Canada Ticker: 0LI70LI7

This company was Merged or Acquired on 4/11/2023.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The Company operates through one business segment: the development, manufacturing and marketing of medical devices. The Company's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The Company carries its business in Canada, the United States and Europe.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202212/31/2022YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Steven D.Rubin 62 6/11/2018 7/1/2008
President, Chief Executive Officer, Director FredColen 1/22/2018 1/22/2018
Chief Financial Officer, Corporate Secretary ChristopherClark 1/1/2015 5/3/2007
8 additional Officers and Directors records available in full report.

Business Names
Business Name
0LI7
B-Balloon Ltd.
Medical Ventures (US) Inc.
9 additional Business Names available in full report.

General Information
Number of Employees: 49 (As of 12/31/2021)
Outstanding Shares: 2,783,553 (As of 3/31/2023)
Stock Exchange: TSE
Fax Number: (604) 270-4384


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, March 17, 2024